Core Scientific, Inc. / Estimates

    Fiscal Year Revenue Net income Net margin Free cash flow FCF margin
    (estimated) €1.98B +37.3% €563.27M -7.8% 28.5% -0.14 pp €577.07M +313.0% 29.2% +0.19 pp
    (estimated) €1.44B +30.3% €611.10M +225.1% 42.4% +0.25 pp €139.74M -28.3% 9.7% -0.079 pp
    (estimated) €1.11B +44.7% €187.98M +220.1% 17.0% +0.093 pp €194.95M -969.2% 17.6% +0.21 pp
    (estimated) €764.44M +103.1% €58.73M +∞% 7.7% +0.077 pp -€22.43M -89.6% -2.9% +0.54 pp
    (estimated) €376.30M -14.6% N/A N/A -€214.78M -280.6% -57.1% -0.84 pp
    €440.50M +1.6% -€1.13B +433.5% -257.5% -2.1 pp €118.91M +69.6% 27.0% +0.11 pp
    €433.36M -21.5% -€212.62M -88.5% -49.1% +2.9 pp €70.11M -86.2% 16.2% -0.76 pp
    €552.33M +17.6% -€1.85B -4,636.5% -335.2% -3.4 pp €508.21M +23,095.6% 92.0% +0.92 pp
    €469.67M +802.7% €40.81M -455,023.1% 8.7% +0.087 pp €2.19M -111.4% 0.5% +0.37 pp
    €52.03M +1.3% -€8.97K -99.9% -0.0% +0.20 pp -€19.15M -160.7% -36.8% -0.98 pp
    €51.34M -€10.28M -20.0% €31.55M 61.5%

    Notifications